A new long-term study of women with stage-4 breast cancer at the Stanford University School of Medicine is likely to revive a decade-old debate about high-dose chemotherapy as a treatment option. Specifically, researchers found that a greater proportion of patients who received the aggressive treatment 12 to 14 years ago, followed by a rescue with their own, specially purified blood stem cells that had been purged of cancer, survived compared with those who were rescued with unmanipulated blood grafts.
marrow transplant Bone breast in cancer
As long as HMOs regarded the regime as experimental or investigational , there was no contractual obligation to cover it. What's happening near you? Hi Gordon.
This selection bias makes the treatment look better, because candidates who would have fared better under any condition were selected. You might also be interested in. They give you drugs to reduce certain side effects.